title: The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.
abstract: This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.
authors.affiliation: Department of Obstetrics and Gynecology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. anasars@convex.com.br
authors.forename: Ana Carolina Japur
authors.initials: AC
authors.lastname: de Sá Rosa e Silva
authors.forename: Júlio Cesar
authors.initials: JC
authors.lastname: Rosa e Silva
authors.forename: Antônio Alberto
authors.initials: AA
authors.lastname: Nogueira
authors.forename: Carlos Alberto
authors.initials: CA
authors.lastname: Petta
authors.forename: Maurício Simões
authors.initials: MS
authors.lastname: Abrão
authors.forename: Rui Alberto
authors.initials: RA
authors.lastname: Ferriani
mesh_terms: D000293:Adolescent; D000328:Adult; D018394:CA-125 Antigen / Q000097:blood*; D003271:Contraceptive Agents, Female / Q000008:administration & dosage; D004715:Endometriosis / Q000097:blood* / Q000188:drug therapy*; D019544:Equipment Failure Analysis; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D018394:CA-125 Antigen; D003271:Contraceptive Agents, Female; D016912:Levonorgestrel